News
RGEN
189.50
+4.29%
7.80
Freshworks to replace BioLife Solutions in S&P 600 at open on 10/8
TipRanks · 3h ago
Weekly Report: what happened at RGEN last week (0928-1002)?
Weekly Report · 14h ago
3 Healthcare Stocks That Concern Us
Barchart · 3d ago
Repligen (RGEN) Stock Looks Stretched After A 32% One Year Run
Simply Wall St · 4d ago
William Blair refreshes its analyst conviction list
Seeking Alpha · 4d ago
New Grades, Price Targets for the Top-3 Stocks in the Market’s Hottest Sector
TipRanks · 6d ago
Biotech Stocks At 52-Week Highs - KOD +177% On Phase 3 Data; GRAL, IOVA, RGEN
NASDAQ · 6d ago
Repligen Buy Rating Reiterated as Analyst Sees Medium-Term Growth Catalysts; Price Target Maintained at $225
TipRanks · 6d ago
Weekly Report: what happened at RGEN last week (0921-0925)?
Weekly Report · 09/28 10:02
Analysts Have Conflicting Sentiments on These Healthcare Companies: Repligen (RGEN) and Capricor Therapeutics (CAPR)
TipRanks · 09/28 06:10
Repligen (RGEN) Trades At A 2% Premium After Board Retirement Update
Simply Wall St · 09/25 08:23
3 Unpopular Stocks Walking a Fine Line
Barchart · 09/23 03:16
Notable Monday Option Activity: RGEN, ASST, INOD
NASDAQ · 09/21 19:49
Weekly Report: what happened at RGEN last week (0914-0918)?
Weekly Report · 09/21 10:02
Repligen (RGEN) Gets a Buy from Stifel Nicolaus
TipRanks · 09/16 09:16
Repligen announces long-serving director Karen Dawes’ retirement
TipRanks · 09/15 20:35
Weekly Report: what happened at RGEN last week (0907-0911)?
Weekly Report · 09/14 10:06
Repligen (RGEN) Stock May Be Near Fair Value As Sales Premium Persists
Simply Wall St · 09/12 09:15
Roche Gets FDA Priority Tag for Enspryng in Rare Autoimmune Disorder
NASDAQ · 09/10 15:42
Novartis' Del-desiran Fails Late-Stage DM1 Study, Shares Fall
NASDAQ · 09/09 18:47
More
Webull provides a variety of real-time RGEN stock news. You can receive the latest news about Repligen through multiple platforms. This information may help you make smarter investment decisions.
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.